Reports for SANDOZ CANADA INCORPORATED

Company Name
SANDOZ CANADA INCORPORATED

Shortage reports

Actual shortage:

35 (1%)

Anticipated shortage:

9 (0%)

Avoided shortage:

19 (1%)

Resolved:

2320 (97%)

2383

Discontinuation Reports

To be discontinued:

3 (2%)

Discontinued:

131 (96%)

Reversed:

2 (1%)

136

466 (18%)

3 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
OMEP 20MG CAPSULE (DELAYED RELEASE) Resolved 2017-09-07 2017-10-25 21295
OMEP 20MG CAPSULE (DELAYED RELEASE) Resolved 2019-12-10 2023-11-17 100818
OMEP 20MG CAPSULE (DELAYED RELEASE) Resolved 2018-02-12 2018-03-24 39575
ONDANSETRON HYDROCHLORIDE DIHYDRATE INJECTION 2MG SOLUTION Resolved 2017-08-07 2017-10-19 18328
ONDANSETRON HYDROCHLORIDE DIHYDRATE INJECTION 2MG SOLUTION Resolved 2019-03-05 2019-04-17 77732
ONDANSETRON INJECTION USP -(PRESERVATIVE FREE) 2MG SOLUTION Resolved 2023-08-21 2024-01-03 202547
ONDANSETRON INJECTION USP -(WITH PRESERVATIVE) 2MG SOLUTION Resolved 2024-12-10 2025-04-22 245205
ONDANSETRON INJECTION USP -(WITH PRESERVATIVE) 2MG SOLUTION Resolved 2017-07-18 2017-10-19 16268
ONDANSETRON INJECTION USP -(WITH PRESERVATIVE) 2MG SOLUTION Resolved 2017-08-07 2017-10-19 18325
ONDANSETRON INJECTION USP -(PRESERVATIVE FREE) 2MG SOLUTION Resolved 2025-05-20 2025-07-01 257756
ONDANSETRON ODT 4MG TABLET (ORALLY DISINTEGRATING) Resolved 2022-08-18 2022-12-28 167327
ONDANSETRON ODT 8MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-10-15 2020-01-22 96488
ONDANSETRON ODT 4MG TABLET (ORALLY DISINTEGRATING) Resolved 2022-01-12 2022-04-20 152599
ONDANSETRON ODT 4MG TABLET (ORALLY DISINTEGRATING) Resolved 2025-06-09 2025-07-08 260000
ONDANSETRON ODT 8MG TABLET (ORALLY DISINTEGRATING) Resolved 2021-09-02 2021-10-20 145004
ONDANSETRON ODT 8MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-03-02 2023-07-05 186070
ONDANSETRON ODT 8MG TABLET (ORALLY DISINTEGRATING) Resolved 2025-01-27 2025-05-20 248648
ONDANSETRON ODT 4MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-12-04 2024-01-31 212454
ONDANSETRON ODT 4MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-03-27 2023-05-09 188061
ONDANSETRON ODT 4MG TABLET (ORALLY DISINTEGRATING) Resolved 2026-02-09 2026-03-03 277649
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ANGIOMAX 250MG POWDER FOR SOLUTION Discontinued 2026-03-16 2026-03-19 280590
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BORTEZOMIB FOR INJECTION SDZ 3.5MG POWDER FOR SOLUTION Discontinued 2026-03-16 2026-03-19 280595
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467
KETOROLAC TROMETHAMINE INJECTION USP 30MG SOLUTION LIQUID Discontinued 2025-08-04 2025-08-05 264341
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265

Showing 1 to 20 of 136